Literature DB >> 9015111

Rotavirus immunity in the mouse.

M A Franco1, N Feng, H B Greenberg.   

Abstract

Naturally attenuated animal rotaviruses have been tested as antirotavirus vaccines with moderate success. The development of improved vaccines will rely on our understanding of the immune mechanism that mediate clearance and protection from rotaviral reinfection. The mouse model of rotavirus infection is a versatile tool for studying these mechanisms: mice have a relative low cost and there is a rapidly increasing number of immunological reagents to study rotavirus immunology. This review covers recent data on the mouse model of rotavirus infection. We show that both effector arms of the immune system (CD8 + T cells and B cells) mediate anti-rotavirus effects in vivo.

Entities:  

Mesh:

Year:  1996        PMID: 9015111     DOI: 10.1007/978-3-7091-6553-9_16

Source DB:  PubMed          Journal:  Arch Virol Suppl        ISSN: 0939-1983


  4 in total

1.  Rotavirus infection activates dendritic cells from Peyer's patches in adult mice.

Authors:  Delia V Lopez-Guerrero; Selene Meza-Perez; Oscar Ramirez-Pliego; Maria A Santana-Calderon; Pavel Espino-Solis; Lourdes Gutierrez-Xicotencatl; Leopoldo Flores-Romo; Fernando R Esquivel-Guadarrama
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

2.  Variation in antagonism of the interferon response to rotavirus NSP1 results in differential infectivity in mouse embryonic fibroblasts.

Authors:  N Feng; A Sen; H Nguyen; P Vo; Y Hoshino; E M Deal; H B Greenberg
Journal:  J Virol       Date:  2009-05-06       Impact factor: 5.103

3.  Role of interferon in homologous and heterologous rotavirus infection in the intestines and extraintestinal organs of suckling mice.

Authors:  N Feng; B Kim; M Fenaux; H Nguyen; P Vo; M B Omary; H B Greenberg
Journal:  J Virol       Date:  2008-05-21       Impact factor: 5.103

4.  Characterization of rotavirus RNAs that activate innate immune signaling through the RIG-I-like receptors.

Authors:  Dina Uzri; Harry B Greenberg
Journal:  PLoS One       Date:  2013-07-23       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.